Cargando…

Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer

PURPOSE: Circulating tumor DNA (ctDNA) detection is a minimally invasive technique that offers dynamic molecular snapshots of genomic alterations in cancer. Although ctDNA markers can be used for early detection of cancers or for monitoring treatment efficacy, the value of ctDNA in guiding treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oikkonen, Jaana, Zhang, Kaiyang, Salminen, Liina, Schulman, Ingrid, Lavikka, Kari, Andersson, Noora, Ojanperä, Erika, Hietanen, Sakari, Grénman, Seija, Lehtonen, Rainer, Huhtinen, Kaisa, Carpén, Olli, Hynninen, Johanna, Färkkilä, Anniina, Hautaniemi, Sampsa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2019
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446450/ https://www.ncbi.nlm.nih.gov/pubmed/32914024 http://dx.doi.org/10.1200/PO.18.00343

Ejemplares similares

QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variability
por: Jamalzadeh, Sanaz, et al.
Publicado: (2022)

Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence
por: Marchi, Giovanni, et al.
Publicado: (2023)

Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer
por: Zhang, Kaiyang, et al.
Publicado: (2022)

Author Correction: Virtual clinical trials identify effective combination therapies in ovarian cancer
por: Kozłowska, Emilia, et al.
Publicado: (2020)

Virtual clinical trials identify effective combination therapies in ovarian cancer
por: Kozłowska, Emilia, et al.
Publicado: (2019)

Agile workflow for interactive analysis of mass cytometry data
por: Casado, Julia, et al.
Publicado: (2020)

PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples
por: Häkkinen, Antti, et al.
Publicado: (2021)

FUNGI: FUsioN Gene Integration toolset
por: Cervera, Alejandra, et al.
Publicado: (2021)

Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer
por: He, Liye, et al.
Publicado: (2021)

Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer
por: Perez-Villatoro, Fernando, et al.
Publicado: (2022)

Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
por: Pikkusaari, Sanna, et al.
Publicado: (2023)

Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
por: Pietilä, Elina A., et al.
Publicado: (2021)

Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality
por: Jukonen, Joonas, et al.
Publicado: (2021)

qSNE: quadratic rate t-SNE optimizer with automatic parameter tuning for large datasets
por: Häkkinen, Antti, et al.
Publicado: (2020)

Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status
por: Roering, Pia, et al.
Publicado: (2022)

Quantification of cell death and proliferation of patient-derived ovarian cancer organoids through 3D imaging and image analysis
por: Skorda, Aikaterini, et al.
Publicado: (2023)

A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer
por: Salminen, Liina, et al.
Publicado: (2021)

H&E image analysis pipeline for quantifying morphological features
por: Ariotta, Valeria, et al.
Publicado: (2023)

Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study
por: Laasik, Maren, et al.
Publicado: (2019)

A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer
por: Carroll, Molly J., et al.
Publicado: (2022)

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids
por: Senkowski, Wojciech, et al.
Publicado: (2023)

Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells’ sensitivity to paclitaxel
por: Tambe, Mahesh, et al.
Publicado: (2016)

REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker
por: Lehtinen, Laura, et al.
Publicado: (2016)

Identification of sample-specific regulations using integrative network level analysis
por: Liu, Chengyu, et al.
Publicado: (2015)

Prevalence, Genotype Distribution and Persistence of Human Papillomavirus in Oral Mucosa of Women: A Six-Year Follow-Up Study
por: Rautava, Jaana, et al.
Publicado: (2012)

Genotype-Specific Incidence and Clearance of Human Papillomavirus in Oral Mucosa of Women: A Six-Year Follow-Up Study
por: Louvanto, Karolina, et al.
Publicado: (2013)

SePIA: RNA and small RNA sequence processing, integration, and analysis
por: Icay, Katherine, et al.
Publicado: (2016)

Data integration to prioritize drugs using genomics and curated data
por: Louhimo, Riku, et al.
Publicado: (2016)

Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors
por: Haltia, Ulla-Maija, et al.
Publicado: (2020)

The feasibility of [(18)F]EF5-PET/CT to image hypoxia in ovarian tumors: a clinical study
por: Laasik, Maren, et al.
Publicado: (2020)

Plasticity of Blood- and Lymphatic Endothelial Cells and Marker Identification
por: Keuschnigg, Johannes, et al.
Publicado: (2013)

Correction: Plasticity of Blood- and Lymphatic Endothelial Cells and Marker Identification
por: Keuschnigg, Johannes, et al.
Publicado: (2013)

Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer
por: Steiner, Aida, et al.
Publicado: (2021)

When actions do not match aspirations - comparison of the European Union policy claims against what has been negotiated for health services, trade and investment
por: Koivusalo, Meri, et al.
Publicado: (2021)

HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor—a long-term follow-up study
por: Färkkilä, Anniina, et al.
Publicado: (2014)

Rule-based induction method for haplotype comparison and identification of candidate disease loci
por: Karinen, Sirkku, et al.
Publicado: (2012)

Comparison of Affymetrix data normalization methods using 6,926 experiments across five array generations
por: Autio, Reija, et al.
Publicado: (2009)

Oral Human Papillomavirus Infection in Children during the First 6 Years of Life, Finland
por: Syrjänen, Stina, et al.
Publicado: (2021)

Functional Profiling of Precursor MicroRNAs Identifies MicroRNAs Essential for Glioma Proliferation
por: Haapa-Paananen, Saija, et al.
Publicado: (2013)

Fast Gene Ontology based clustering for microarray experiments
por: Ovaska, Kristian, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_urfupspa256pvp76a9odeumbkp